6,6'-dicorynomycolyl trehalose has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himeno, S; Imagawa, H; Inoue, M; Nagahama, M; Nakano, M; Nishizawa, M; Oda, M; Sakurai, J; Setsu, K; Shibutani, M; Watanabe, N; Yabiku, K; Yamamoto, H | 1 |
| Azuma, I; Garcia, DM; Hata, K; Imagawa, H; Koike, Y; Mitobe, M; Nishizawa, M; Nobuchi, Y; Watanabe, R; Yamada, H; Yoo, YC | 1 |
2 other study(ies) available for 6,6'-dicorynomycolyl trehalose and Lung Neoplasms
| Article | Year |
|---|---|
Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cord Factors; Glycolipids; Humans; In Vitro Techniques; Lung Neoplasms; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phagocytosis; Stereoisomerism; Structure-Activity Relationship; Trehalose; Xenograft Model Antitumor Assays | 2013 |
Inhibitory effect of trehalose dimycolate (TDM) and its stereoisometric derivatives, trehalose dicorynomycolates (TDCMs), with low toxicity on lung metastasis of tumour cells in mice.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Colonic Neoplasms; Cord Factors; Female; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Chemical; Neoplasm Metastasis; Stereoisomerism | 1999 |